Astroglial FMRP modulates synaptic signaling and behavior phenotypes in FXS mouse model

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Fragile X syndrome (FXS) is a leading inherited cause of intellectual disability, linked to FMRP protein deficiency and altered cellular signaling.
• While neuronal roles in FXS are known, the contribution of other central nervous system (CNS) cell types, like astrocytes, to FXS phenotypes remains unclear.
• Previous studies suggest astroglial FMRP loss impacts glutamate uptake, spine density, and motor learning.

Purpose of the Study:

• To investigate the specific role of astroglial Fragile X mental retardation protein (FMRP) in synaptic signaling, behavior, and learning relevant to FXS.
• To determine if selectively reducing or restoring FMRP in astrocytes influences FXS-related phenotypes.

Main Methods:

• Utilized astroglial Fmr1 conditional knockout (cKO) and conditional ON (cON) mouse models to manipulate FMRP expression in astrocytes.
• Assessed synaptic function through electrophysiological recordings, focusing on excitatory postsynaptic currents (EPSCs) and cortical UP states.
• Evaluated behavioral phenotypes including locomotor activity, social interaction (novelty preference), and learning/memory (acquisition and extinction).

Main Results:

• Selective loss of astroglial FMRP in cKO mice led to cortical hyperexcitability, characterized by enhanced NMDAR-mediated evoked EPSCs and prolonged cortical UP states.
• Astroglial FMRP deficiency resulted in increased hyperactivity, reduced social novelty preference, and deficits in memory acquisition and extinction.
• Restoring FMRP in astrocytes of cON mice significantly rescued hyperactivity and normalized social novelty preference.

Conclusions:

• Astroglial FMRP plays a critical role in regulating synaptic excitability, cortical network activity, and behavioral outcomes associated with Fragile X syndrome.
• These findings highlight astrocytes as key cellular players in FXS pathogenesis and suggest targeting astroglial FMRP could be a viable therapeutic strategy.
• Cell-type-specific FMRP restoration strategies are important for developing effective treatments for FXS.